Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01788410 · ClinicalTrials.gov registry record
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine
A clinical trial of Neuropathy and Neuralgia, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT01788410: Recruiting study of Neuropathy and Neuralgia, sponsored by Brigham and Women's Hospital.
NCT01788410 is a study of Neuropathy and Neuralgia that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 50 participants, below the 184-participant average among 22 other Neuropathy trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01788410, a study of Neuropathy and Neuralgia, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to provide pain relief to patients with facet joint disease or head and neck pain related to compression of a nerve root. The goal is to provide palliative care with superior efficacy and longer relief compared to current methods.
Primary Outcome
We will be grading patients pain using the "Brief Pain Inventory" pre-ablation and 1 month post-ablation.
Conditions Studied
Interventions
- PROCEDURE Cryoablation under image guidance
- DEVICE MRI Seednet Cryotherapy System (Galil Medical)
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-05 |
| Est. Completion | 2030-05 |
What NCT01788410 shows while recruiting
NCT01788410 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 184-participant average among 22 other Neuropathy trials with a reported enrollment target (73% lower).
The record links to 3 conditions, with Neuropathy appearing as the primary indexed condition, and to 2 interventions - of which Cryoablation under image guidance is the first listed.
NCT01788410 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01788410 about?
NCT01788410 is a clinical study titled "MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine". The objective of this study is to provide pain relief to patients with facet joint disease or head and neck pain related to compression of a nerve root. The goal is to provide palliative care with superior efficacy and longer relief compared to current methods.
What is the current status of trial NCT01788410?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2013-05. Estimated completion is 2030-05.
What conditions does trial NCT01788410 study?
This clinical trial studies the following conditions: Neuropathy, Neuralgia, Facet Joints; Degeneration.
What interventions are being tested in trial NCT01788410?
The interventions under investigation include: Cryoablation under image guidance (PROCEDURE), MRI Seednet Cryotherapy System (Galil Medical) (DEVICE).
Who is sponsoring clinical trial NCT01788410?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01788410 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01788410's enrollment target sits among peer trials
50 17th of 22 higher than 5 of 22 other Neuropathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neuropathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
RECRUITING · NA
-
Diabetic Neuropathy in Spinal Cord Stimulator Patients
RECRUITING
-
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
RECRUITING
-
IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
RECRUITING
-
Daily Hand-Held Vibration Therapy
RECRUITING · NA
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia